JP2009513700A5 - - Google Patents

Download PDF

Info

Publication number
JP2009513700A5
JP2009513700A5 JP2008538915A JP2008538915A JP2009513700A5 JP 2009513700 A5 JP2009513700 A5 JP 2009513700A5 JP 2008538915 A JP2008538915 A JP 2008538915A JP 2008538915 A JP2008538915 A JP 2008538915A JP 2009513700 A5 JP2009513700 A5 JP 2009513700A5
Authority
JP
Japan
Prior art keywords
saturated
alkyl
partially unsaturated
heteroaryl
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008538915A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009513700A (ja
JP5137207B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/041251 external-priority patent/WO2007053345A1/en
Publication of JP2009513700A publication Critical patent/JP2009513700A/ja
Publication of JP2009513700A5 publication Critical patent/JP2009513700A5/ja
Application granted granted Critical
Publication of JP5137207B2 publication Critical patent/JP5137207B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008538915A 2005-11-01 2006-10-24 グルコキナーゼ活性化因子 Expired - Fee Related JP5137207B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73203705P 2005-11-01 2005-11-01
US60/732,037 2005-11-01
PCT/US2006/041251 WO2007053345A1 (en) 2005-11-01 2006-10-24 Glucokinase activators

Publications (3)

Publication Number Publication Date
JP2009513700A JP2009513700A (ja) 2009-04-02
JP2009513700A5 true JP2009513700A5 (enExample) 2009-10-22
JP5137207B2 JP5137207B2 (ja) 2013-02-06

Family

ID=37685330

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008538915A Expired - Fee Related JP5137207B2 (ja) 2005-11-01 2006-10-24 グルコキナーゼ活性化因子

Country Status (9)

Country Link
US (1) US8933077B2 (enExample)
EP (1) EP1948652B1 (enExample)
JP (1) JP5137207B2 (enExample)
AT (1) ATE521608T1 (enExample)
AU (1) AU2006309173B2 (enExample)
CA (1) CA2628274A1 (enExample)
ES (1) ES2372540T3 (enExample)
NZ (1) NZ567858A (enExample)
WO (1) WO2007053345A1 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1785420A1 (en) * 2005-11-14 2007-05-16 4Sc Ag Thiazole analogues and uses thereof
AU2007283113A1 (en) 2006-08-08 2008-02-14 Sanofi-Aventis Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
CA2681695A1 (en) * 2007-03-23 2008-10-02 Array Biopharma Inc. 2-aminopyridine analogs as glucokinase activators
WO2009022179A2 (en) * 2007-08-14 2009-02-19 Astrazeneca Ab Glucokinase activators in the treatment of osteoarthritis
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
SI2209778T1 (sl) * 2007-09-21 2012-12-31 Array Biopharma, Inc. Piridin-2-il-amino-I, 2,4-tiadiazol derivati kot aktivatorji glukokinaze za zdravljenje sladkorne bolezni
AU2008310097B2 (en) 2007-10-09 2013-05-16 Merck Patent Gmbh Pyridine derivatives useful as glucokinase activators
US20100267708A1 (en) 2007-12-20 2010-10-21 Lg Life Sciences Ltd. Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient
US8470841B2 (en) 2008-07-09 2013-06-25 Sanofi Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
US20120058984A1 (en) * 2009-03-17 2012-03-08 Catherine Mary Alder Pyrimidine derivatives used as itk inhibitors
EP2451817B1 (en) * 2009-07-10 2013-09-04 Bayer Intellectual Property GmbH Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof
JP2013503135A (ja) 2009-08-26 2013-01-31 サノフイ 新規な結晶性複素芳香族フルオログリコシド水和物、その化合物を含んでなる医薬及びその使用
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
CA2800498C (en) 2010-03-31 2021-11-16 The Scripps Research Institute Reprogramming cells
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120054A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
JPWO2012121314A1 (ja) 2011-03-09 2014-07-17 第一三共株式会社 ジピリジルアミン誘導体
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
JP2015505536A (ja) * 2012-01-20 2015-02-23 アクセラ インク． 疾患の処置のための置換された複素環化合物
JP6177894B2 (ja) 2012-05-18 2017-08-09 アムジェン インコーポレイテッド チアジアゾールの調製方法
US11357759B2 (en) 2017-10-29 2022-06-14 China Medical University Composition including ADAM9 inhibitor and the use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596476B1 (en) * 1989-12-22 2003-07-22 Abbott Laboratories Hepatitis C assay
US7125875B2 (en) * 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
EP2308833A3 (en) 1999-04-15 2011-09-28 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
HUP0202682A3 (en) * 1999-09-10 2003-03-28 Merck & Co Inc Tyrosine kinase inhibitors, pharmaceutical compositions containing them and their use
CA2432799C (en) * 2000-12-21 2008-08-19 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
GB0226931D0 (en) * 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
MXPA05008619A (es) * 2003-02-13 2005-11-04 Banyu Pharma Co Ltd Derivados novedosos de 2-piridincarboxamida.
EP1734040A4 (en) * 2004-03-23 2007-11-28 Banyu Pharma Co Ltd SUBSTITUTED CHINAZOLINE OR PYRIDOPYRIMIDINE DERIVATIVE

Similar Documents

Publication Publication Date Title
JP2009513700A5 (enExample)
CA2917267C (en) Cyanotriazole compounds
EP2247586B1 (en) 2-aza-bicyclo[2.2.1]heptane derivatives
AU2007351498B2 (en) Organic compounds
KR101178747B1 (ko) 프로톤 펌프 저해제
CN102171204B (zh) 8位取代异喹啉衍生物及其用途
JP5040656B2 (ja) トリアリールカルボン酸誘導体
JP2009524670A5 (enExample)
BG107284A (bg) Заместени пиролопиридинонови производни полезни като инхибитори на фосфодиестераза
JP2015503529A5 (enExample)
JP2013507355A (ja) キサンチンオキシダーゼ阻害剤として効果的な新規化合物、その製造方法及びそれを含有する医薬組成物
CZ20023199A3 (cs) Modulátory receptoru adenosinu
CN103124730A (zh) 杂环炔苯类化合物及其药用组合物和应用
TW200819443A (en) An imidazole derivative
WO1999061436A1 (en) Heterocyclic indole derivatives and mono- or diazaindole derivatives
CN101784276A (zh) 化合物在用于制备抗结核药剂中的用途
JP6559699B2 (ja) 置換含窒素複素環誘導体、それを含む医薬組成物及びその抗腫瘍性の適用
FR2911139A1 (fr) Nouveaux derives de phenyl-(4-phenyl-pyrimidin-2-yl)amines, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
CA2251681A1 (en) Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
CN114901658A (zh) 含氮杂环类自分泌运动因子抑制剂及其组合物和用途
HRP20040874A2 (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
KR20250121546A (ko) Gpr17 조절제 및 이의 용도
JP2001506666A (ja) イミダゾピリダジン
CN112469714A (zh) 作为端锚聚合酶抑制剂的1,2,4-三唑衍生物
AU698249B2 (en) Thiopyridines for combating (helicobacter) bacteria